Cover Image
Market Research Report

Latin America, Middle East & Africa Genetic Testing Market (2019-2025)

Published by KBV Research Product code 911082
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
Latin America, Middle East & Africa Genetic Testing Market (2019-2025)
Published: August 31, 2019 Content info: 90 Pages
Description

The Latin America, Middle East and Africa Genetic Testing Market would witness market growth of 12.3% CAGR during the forecast period (2019-2025).

Carrier testing is used to detect individuals bearing a copy of a gene mutation that creates a genetic illness when present in two copies. This kind of tests is available for persons with a genetic disorder in family history and persons with an increased danger of specific genetic conditions in certain ethnic groups. The test can provide data about a couple's danger of a kid with a genetic disease if both parents are tested.

The increase in the incidence of genetic disorders and cancer plays an important role in the development of the genetic testing industry. In addition, an increase in personalized medicine therapy is anticipated in the coming years to increase the market growth. However, standardization disagreements about genetic test-based diagnostics and strict legislative requirements for product approvals are expected to hamper the development of the genetic testing market during the prediction period.

Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).

Scope of the Study

Market Segmentation:

By Type

  • Predictive and Presymptomatic Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Other Types

By Technology

  • Cytogenetic Testing
  • Biochemical Testing and
  • Molecular Testing

By Application

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis and
  • Other Applications

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled:

  • Myriad Genetics, Inc.
  • Empire Genomics LLC
  • Bio-Rad Laboratories, Inc.
  • Novartis AG
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Danaher Corporation
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Genetic Testing Market, by Type
    • 1.4.2 LAMEA Genetic Testing Market, by Technology
    • 1.4.3 LAMEA Genetic Testing Market, by Application
    • 1.4.4 LAMEA Genetic Testing Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Executive Summary
    • 2.1.3 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Genetic Testing Market by Type

  • 3.1 LAMEA Predictive and Presymptomatic Testing Market by Country
  • 3.2 LAMEA Carrier Testing Market by Country
  • 3.3 LAMEA Prenatal and Newborn Testing Market by Country
  • 3.4 LAMEA Diagnostic Testing Market by Country
  • 3.5 LAMEA Pharmacogenomic Testing Market by Country
  • 3.6 LAMEA Other Types Genetic Testing Market by Country

Chapter 4. LAMEA Genetic Testing Market by Technology

  • 4.1 LAMEA Cytogenetic Testing Market by Country
  • 4.2 LAMEA Biochemical Testing Market by Country
  • 4.3 LAMEA Molecular Testing Market by Country

Chapter 5. LAMEA Genetic Testing Market by Application

  • 5.1 LAMEA Cancer Diagnosis Market by Country
  • 5.2 LAMEA Genetic Disease Diagnosis Market by Country
  • 5.3 LAMEA Cardiovascular Disease Diagnosis Market by Country
  • 5.4 LAMEA Other Applications Market by Country

Chapter 6. LAMEA Genetic Testing Market by Country

  • 6.1 Brazil Genetic Testing Market
    • 6.1.1 Brazil Genetic Testing Market by Type
    • 6.1.2 Brazil Genetic Testing Market by Technology
    • 6.1.3 Brazil Genetic Testing Market by Application
  • 6.2 Argentina Genetic Testing Market
    • 6.2.1 Argentina Genetic Testing Market by Type
    • 6.2.2 Argentina Genetic Testing Market by Technology
    • 6.2.3 Argentina Genetic Testing Market by Application
  • 6.3 UAE Genetic Testing Market
    • 6.3.1 UAE Genetic Testing Market by Type
    • 6.3.2 UAE Genetic Testing Market by Technology
    • 6.3.3 UAE Genetic Testing Market by Application
  • 6.4 Saudi Arabia Genetic Testing Market
    • 6.4.1 Saudi Arabia Genetic Testing Market by Type
    • 6.4.2 Saudi Arabia Genetic Testing Market by Technology
    • 6.4.3 Saudi Arabia Genetic Testing Market by Application
  • 6.5 South Africa Genetic Testing Market
    • 6.5.1 South Africa Genetic Testing Market by Type
    • 6.5.2 South Africa Genetic Testing Market by Technology
    • 6.5.3 South Africa Genetic Testing Market by Application
  • 6.6 Nigeria Genetic Testing Market
    • 6.6.1 Nigeria Genetic Testing Market by Type
    • 6.6.2 Nigeria Genetic Testing Market by Technology
    • 6.6.3 Nigeria Genetic Testing Market by Application
  • 6.7 Rest of LAMEA Genetic Testing Market
    • 6.7.1 Rest of LAMEA Genetic Testing Market by Type
    • 6.7.2 Rest of LAMEA Genetic Testing Market by Technology
    • 6.7.3 Rest of LAMEA Genetic Testing Market by Application

Chapter 7. Company Profiles

  • 7.1 Myriad Genetics, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Product Launches:
      • 7.1.5.2 Collaborations, Partnerships and agreements:
  • 7.2 Empire Genomics LLC
    • 7.2.1 Company Overview
  • 7.3 Bio-Rad laboratories, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Collaborations, partnerships and agreements:
      • 7.3.4.2 Product launches:
      • 7.3.4.3 Acquisition and mergers:
    • 7.3.5 Research & Development Expenses
  • 7.4 Novartis AG
    • 7.4.1 Company Overview
    • 7.4.1 Financial Analysis
    • 7.4.2 Segmental and Regional Analysis
    • 7.4.3 Research & Development Expense
    • 7.4.4 Recent strategies and developments:
      • 7.4.4.1 Collaborations, partnerships and agreements:
  • 7.5 Agilent Technologies, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Product launches:
      • 7.5.5.2 Expansions:
  • 7.6 Thermo Fischer Scientific, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
  • 7.7 Qiagen N.V.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product launches:
      • 7.7.5.2 Collaborations, partnerships and agreements:
  • 7.8 Illumina, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
      • 7.8.5.2 Product launches:
  • 7.9 Danaher Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Acquisition and mergers:
  • 7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Collaborations, partnerships and agreements:
      • 7.10.5.2 Product launches:

LIST OF TABLES

  • TABLE 1 LAMEA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 LAMEA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 LAMEA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 4 LAMEA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 5 LAMEA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 6 LAMEA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 7 LAMEA CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 8 LAMEA CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 9 LAMEA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 10 LAMEA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 11 LAMEA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 12 LAMEA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 13 LAMEA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 14 LAMEA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 15 LAMEA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 16 LAMEA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 17 LAMEA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 18 LAMEA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 19 LAMEA CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 20 LAMEA CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 21 LAMEA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 22 LAMEA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 23 LAMEA MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 24 LAMEA MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 25 LAMEA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 26 LAMEA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 27 LAMEA CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 28 LAMEA CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 29 LAMEA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 30 LAMEA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 31 LAMEA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 32 LAMEA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 33 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 34 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 35 LAMEA GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 36 LAMEA GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 37 BRAZIL GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 38 BRAZIL GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 39 BRAZIL GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 40 BRAZIL GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 41 BRAZIL GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 42 BRAZIL GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 43 BRAZIL GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 44 BRAZIL GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 45 ARGENTINA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 46 ARGENTINA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 47 ARGENTINA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 48 ARGENTINA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 49 ARGENTINA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 50 ARGENTINA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 51 ARGENTINA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 52 ARGENTINA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 53 UAE GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 UAE GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 UAE GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 56 UAE GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 57 UAE GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 58 UAE GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 59 UAE GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 60 UAE GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 61 SAUDI ARABIA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 62 SAUDI ARABIA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 63 SAUDI ARABIA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 64 SAUDI ARABIA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 65 SAUDI ARABIA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 66 SAUDI ARABIA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 67 SAUDI ARABIA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 68 SAUDI ARABIA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 69 SOUTH AFRICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 70 SOUTH AFRICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 71 SOUTH AFRICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 72 SOUTH AFRICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 73 SOUTH AFRICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 74 SOUTH AFRICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 75 SOUTH AFRICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 76 SOUTH AFRICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 77 NIGERIA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 78 NIGERIA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 79 NIGERIA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 80 NIGERIA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 81 NIGERIA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 82 NIGERIA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 83 NIGERIA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 84 NIGERIA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 85 REST OF LAMEA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 86 REST OF LAMEA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 87 REST OF LAMEA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 88 REST OF LAMEA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 89 REST OF LAMEA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 90 REST OF LAMEA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 91 REST OF LAMEA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 92 REST OF LAMEA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 93 KEY INFORMATION - MYRIAD GENETICS, INC.
  • TABLE 94 KEY INFORMATION - EMPIRE GENOMICS LLC
  • TABLE 95 KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 96 KEY INFORMATION - NOVARTIS AG
  • TABLE 97 KEY INFORMATION - AGILENT TECHNOLOGIES, INC.
  • TABLE 98 KEY INFORMATION - THERMO FISHER SCIENTIFIC, INC.
  • TABLE 99 KEY INFORMATION - QIAGEN N.V.
  • TABLE 100 KEY INFORMATION - ILLUMINA, INC.
  • TABLE 101 KEY INFORMATION - DANAHER CORPORATION
  • TABLE 102 KEY INFORMATION - ABBOTT LABORATORIES

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top